Cancer precursors and their control by BCG

Area of Science:

• Immunology
• Oncology
• Developmental Biology

Background:

• Fetal rests (remnants of embryonic tissue) can persist throughout life and are implicated as precursors to cancer.
• Malignant tumors often express fetal antigens, cross-react with anti-fetal antibodies, and secrete fetal products.
• The infant immune system is immature, yet plays a crucial role in immune surveillance.

Purpose of the Study:

• To propose a theory linking immune system stimulation at birth to the detection and destruction of embryonic cells that may lead to cancer.
• To investigate the potential of early-life immune interventions for lifelong cancer prevention.
• To evaluate the impact of Bacillus Calmette-Guérin (BCG) vaccination on cancer mortality in newborns.

Main Methods:

• Review of existing evidence on fetal rests, fetal antigens in tumors, and immune deficiency-related malignancy.
• Analysis of long-term follow-up data from a large cohort of BCG-vaccinated newborns.
• Comparison of cancer death rates between BCG-vaccinated and unvaccinated groups.

Main Results:

• BCG vaccination in 85,353 newborns was associated with a 74% reduction in overall cancer death rate over 20 years.
• The observed reduction in cancer mortality among vaccinated infants was statistically significant.
• International symposium data supports the hypothesis that early BCG vaccination lowers cancer and leukemia mortality.

Conclusions:

• Early stimulation of the immune system, such as through BCG vaccination at birth, may offer significant protection against cancer development throughout life.
• The immune system's ability to recognize and eliminate embryonic remnants is a critical factor in cancer prevention.
• Further research into immune system modulation in infancy holds promise for long-term cancer control strategies.